Skip to content

13F-HR filed by First Turn Management, LLC

First Turn Management, LLC filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-13, with 33 holding rows worth $875,203,990.

Accession
0001993440-26-000001
Filed
2026-02-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2025

A holdings report, 33 entries on the cover page, a total value of $875,203,990 stated on the cover page (in dollars after the unit check, H1), rows summing to $875,203,990 with VALUE read as dollars as filed, 13F file number 028-23631. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ABIVAX SA-00370M103SPONSORED ADS381,233$51,411,176dollars as filed
REVOLUTION MEDICINES INC COM76155X100Stock638,385$50,847,365dollars as filed
INSMED INC COM PAR $.01457669307Stock264,293$45,997,554dollars as filed
BRIDGEBIO PHARMA INC10806X102COM595,473$45,547,730dollars as filed
MIRUM PHARMACEUTICALS INC604749101COM481,564$38,038,740dollars as filed
AXSOME THERAPEUTICS INC. COM05464T104Stock206,921$37,792,051dollars as filed
NUVALENT INC COM670703107Stock368,697$37,087,231dollars as filed
XENON PHARMACEUTICALS INC COM98420N105Stock799,743$35,844,481dollars as filed
APOGEE THERAPEUTICS INC COM03770N101Stock474,839$35,840,848dollars as filed
TERNS PHARMACEUTICALS INC COM880881107Stock872,049$35,230,780dollars as filed
NEWAMSTERDAM PHARMA CO NVN62509109COMMON STOCK893,473$31,343,033dollars as filed
UNITED THERAPEUTICS CORP DEL COM91307C102Stock63,580$30,979,355dollars as filed
VERA THERAPEUTICS INC92337R101COMMON STOCK601,774$30,473,835dollars as filed
COGENT BIOSCIENCES INC19240Q201COM824,283$29,278,532dollars as filed
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR131,808$28,106,738dollars as filed
GUARDANT HEALTH INC COM40131M109Stock271,685$27,749,906dollars as filed
ROIVANT SCIENCES LTDG76279101SHS1,186,817$25,753,929dollars as filed
IDEAYA BIOSCIENCES INC COM45166A102Stock723,653$25,016,684dollars as filed
VIRIDIAN THERAPEUTICS INC92790C104COM690,528$21,489,231dollars as filed
FULCRUM THERAPEUTICS INC359616109COMMON STOCK1,892,683$21,406,245dollars as filed
CYTOKINETICS INC23282W605COM NEW325,668$20,692,945dollars as filed
SCHOLAR ROCK HLDG CORP80706P103COM459,727$20,250,974dollars as filed
ARGENX SE SPONSORED ADR04016X101ADR23,256$19,557,133dollars as filed
NATERA INC COM632307104Stock80,875$18,527,654dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM2,010,307$16,444,311dollars as filed
KYMERA THERAPEUTICS INC501575104COM206,445$16,063,485dollars as filed
RHYTHM PHARMACEUTICALS INC76243J105COM146,303$15,660,273dollars as filed
OLEMA PHARMACEUTICALS INC68062P106COM617,714$15,442,850dollars as filed
ARCUS BIOSCIENCES INC03969F109COM565,142$13,467,334dollars as filed
DISC MEDICINE INC COM254604101Stock153,206$12,166,088dollars as filed
PRAXIS PRECISION MEDICINES I74006W207COM NEW35,749$10,536,660dollars as filed
UNIQURE NVN90064101SHS321,655$7,697,204dollars as filed
MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD61559X104Stock262,643$3,461,635dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001993440-26-000001this filing2026-02-13acceptance time not in the bulk data set